about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Read More
1.89
-0.02
(-1.05%)
61,121.9
XNAS Volume
XNAS 13 Mar, 2026 4:01 PM (EDT)
Board Meeting
The board meeting for IN8bio Inc is scheduled for today, for the purpose of IN8bio Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..